First-principles calculation of pKa for cocaine, nicotine, neurotransmitters, and anilines in aqueous solution.
The absolute pKa values of 24 representative amine compounds, including cocaine, nicotine, 10 neurotransmitters, and 12 anilines, in aqueous solution were calculated by performing first-principles electronic structure calculations that account for the solvent effects using four different solvation models, i.e., the surface and volume polarization for electrostatic interaction (SVPE) model, the standard polarizable continuum model (PCM), the integral equation formalism for the polarizable continuum model (IEFPCM), and the conductor-like screening solvation model (COSMO). Within the examined computational methods, the calculations using the SVPE model lead to the absolute pKa values with the smallest root-mean-square-deviation (rmsd) value (1.18). When the SVPE model was replaced by the PCM, IEFPCM, and COSMO, the rmsd value of the calculated absolute pKa values became 3.21, 2.72, and 3.08, respectively. All types of calculated pKa values linearly correlate with the experimental pKa values very well. With the empirical corrections using the linear correlation relationships, the theoretical pKa values are much closer to the corresponding experimental data and the rmsd values become 0.51-0.83. The smallest rmsd value (0.51) is also associated with the SVPE model. All of the results suggest that the first-principles electronic structure calculations using the SVPE model are a reliable approach to the pKa prediction for the amine compounds.
Lu
Haiting
H
Key Laboratory of Pesticide & Chemical Biology of the Ministry of Education, College of Chemistry, Central China Normal University, Wuhan 430079, P. R. China.
Chen
Xi
X
Zhan
Chang-Guo
CG
D000814:Aniline Compounds / Q000737:chemistry*; D003042:Cocaine / Q000737:chemistry*; D007700:Kinetics; D018377:Neurotransmitter Agents / Q000737:chemistry*; D009538:Nicotine / Q000737:chemistry*; D012996:Solutions; D055672:Static Electricity; D013816:Thermodynamics; D014867:Water / Q000737:chemistry
D000814:Aniline Compounds; D018377:Neurotransmitter Agents; D012996:Solutions; D014867:Water; D009538:Nicotine; D003042:Cocaine
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16656-61
16275916
Curr Top Med Chem. 2004;4(3):299-334
14754449
J Am Chem Soc. 2001 Mar 28;123(12):2835-8
11456970
N Engl J Med. 1996 Apr 11;334(15):965-72
8596599
J Am Chem Soc. 2002 May 8;124(18):5010-8
11982365
J Am Chem Soc. 2005 Oct 19;127(41):14401-14
16218635
J Phys Chem A. 2006 Nov 23;110(46):12644-52
17107116
Chem Rev. 1999 Aug 11;99(8):2161-2200
11849023
J Phys Chem A. 2006 Oct 5;110(39):11371-6
17004748
Science. 2004 Nov 5;306(5698):983-5
15528431
J Am Chem Soc. 2003 Mar 5;125(9):2770-85
12603166
J Comput Chem. 2005 Jul 30;26(10):980-6
15880781
J Am Chem Soc. 2001 Aug 1;123(30):7314-9
11472159
Bioorg Med Chem Lett. 2004 Dec 6;14(23):5827-30
15501049
Neuron. 2004 Mar 25;41(6):841-2
15046715
Nat Rev Neurosci. 2002 Feb;3(2):102-14
11836518
Bioorg Med Chem Lett. 2004 Apr 19;14(8):1863-7
15050617
J Phys Chem B. 2006 Aug 17;110(32):16066-81
16898764
Proteins. 2006 Jan 1;62(1):99-110
16288482
Science. 2004 Dec 10;306(5703):1944-7
15591205
Bioorg Med Chem Lett. 2005 Sep 1;15(17):3874-80
16005216
Phys Rev B Condens Matter. 1988 Jan 15;37(2):785-789
9944570
Z Naturforsch C Biosci. 1983 Sep-Oct;38(9-10):758-62
6649793
J Chem Phys. 2006 Jun 14;124(22):224111
16784267
J Pharmacol Exp Ther. 1997 Oct;283(1):235-46
9336329
J Phys Chem B. 2006 May 11;110(18):9270-9
16671744
Trends Neurosci. 2004 Jun;27(6):329-36
15165737
J Med Chem. 2002 Jul 18;45(15):3235-45
12109907
J Phys Chem B. 2005 Dec 8;109(48):23070-6
16854005
Biophys J. 2005 Dec;89(6):3863-72
16319079
J Phys Chem A. 2003 Nov 6;107(44):9380-6
26313337
Science. 2004 Nov 5;306(5698):1029-32
15528443
Curr Med Chem. 2000 Aug;7(8):749-800
10828287
J Chem Theory Comput. 2006 Nov;2(6):1520-9
26627022
J Phys Chem A. 2006 Nov 2;110(43):12044-54
17064194
J Med Chem. 2006 Dec 28;49(26):7661-74
17181149
Nature. 2003 Jun 26;423(6943):949-55
12827192
Bioorg Med Chem Lett. 2004 Apr 19;14(8):1869-74
15050618
J Am Chem Soc. 2002 Mar 20;124(11):2744-52
11890826
J Pharmacol Exp Ther. 2004 Sep;310(3):1035-45
15121762
J Med Chem. 2004 Jan 1;47(1):133-42
14695827
J Phys Chem B. 2008 Feb 21;112(7):2085-94
18220380
Curr Opin Pharmacol. 2005 Feb;5(1):53-9
15661626
Chemphyschem. 2004 Oct 18;5(10):1513-22
15535550
Curr Med Chem. 2001 May;8(6):651-74
11281847
J Chem Theory Comput. 2005 Sep;1(5):801-16
26641896
J Am Chem Soc. 2003 Mar 5;125(9):2462-74
12603134
J Med Chem. 2001 Dec 20;44(26):4704-15
11741488
J Pharmacol Exp Ther. 2003 Jan;304(1):400-10
12490617
Drug Alcohol Depend. 1997 Dec 15;48(3):159-65
9449014
J Am Chem Soc. 2002 Jun 5;124(22):6421-7
12033873
Chem Rev. 2000 Mar 8;100(3):925-1024
11749256
Science. 1992 Apr 10;256(5054):213-7
17744720
J Phys Chem B. 2005 Mar 17;109(10):4776-82
16851561
J Med Chem. 2001 Jun 21;44(13):2229-37
11405659
J Med Chem. 2003 Mar 13;46(6):921-4
12620069
Angew Chem Int Ed Engl. 2006 Jan 16;45(4):653-7
16355430
J Org Chem. 2004 Nov 26;69(24):8451-8
15549820
Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):231-41
9164577
Drug Alcohol Depend. 1997 Dec 15;48(3):149-51
9449012
Trends Neurosci. 2004 Sep;27(9):561-8
15331239